期刊文献+

IFITM3真核表达载体的构建和细胞内定位研究 被引量:1

Construction and Expression of Eukaryotic Expressing Vector of Interfern Induced Transmembrane Protein
下载PDF
导出
摘要 目的构建人干扰素诱导的跨膜蛋白3(IFITM3)的真核表达载体并观察其表达产物的细胞内定位,以研究IFITM3的蛋白功能及作用机制。方法提取人外周血淋巴细胞mRNA,行RT-PCR扩增IFITM3编码序列并经琼脂糖凝胶电泳鉴定片段大小,PCR产物及真核表达载体pEGFP-C2经酶切、连接、转化入Top10菌株进行筛选和扩增,重组的pEGFP-C2-IFITM3载体用酶切及DNA测序鉴定其插入序列的正确性,进而转染该重组真核表达载体进入sy5y细胞,倒置荧光共聚焦显微镜观察融合蛋白在细胞内定位。结果琼脂糖凝胶电泳显示经RT-PCR的扩增产物与IFITM3编码区的实际长度相吻合,重组入绿色荧光载体pEGFP-C2的pEGFP-C2-IFITM3经酶切和测序显示实际连入的DNA片段大小、序列及读码框均正确。经真核表达后,重组蛋白定位于细胞膜和在细胞内存在颗粒样聚集。结论成功构建IFITM3的真核表达载体,该载体表达的IFITM3融合蛋白在细胞内定位清晰,为后续的IFITM3功能研究奠定了基础。 Objective To construct eukaryotic expressing vector of interfern induced transmembrane protein ( IFITM3 ) gene and to detect the localization of IFITM3 protein by transfecting into sy5y cell line for its gene function research. Methods mRNA was extracted from peripheral lymphocytes and coding sequence (CDS) of IFITM3 was amplifieated by reverse transcript PCR. The restriction enzymes and T4 ligase were used to insert the amplified DNA sequence into the pEGFP-C2 vector. The enzyme digestion analysis and sequencing were used to confirm the pEGFP-C2-IFITM3 recombinant vector. The localization of IFITM3 was detected by transfecting the recombinant vector into sySy cells. Results CDS of IFITM3 gene was correctly amplified from lymphocytes by RT-PCR. pEGFP-C2-IFITM3 recombinant expression vector was constructed, conformed and further transfected for localization. GFP-IFITM3 fusion protein was localized in cell membrane and part of cell plasma cultured in vitro. Conclusion Eukaryotic expression vector of IF- ITM3 has been successfully constructed and expressed, and provided a good foundation for the further study of the molecular roles of IFITM3.
出处 《标记免疫分析与临床》 CAS 2012年第1期39-43,共5页 Labeled Immunoassays and Clinical Medicine
基金 国家自然科学基金(No.30672258 No.30872788和No.30973981) 北京市科委基金(No.Z09050700940903) 首都医科大学基础-临床科研合作课题(No.11JL53)
关键词 干扰素诱导的跨膜蛋白3 膜蛋白 PEGFP-C2 真核表达 IFITM3 Membrane protein pEGFP-C2 Eukaryotic expression
  • 相关文献

参考文献13

  • 1Lewin A R,Reid L E,McMahon M,et al.Molecular analysis of ahuman interferon-inducible gene family[J].Eur J Biochem,1991,199:417-423.
  • 2Brass A L,Huang I C,Benita Y,et al.The IFITM proteins medi-ate cellular resistance to influenza A H1N1 virus,West Nile virus,and dengue virus[J].Cell,2009,139(7):1243-1254.
  • 3Jiang D,Weidner J M,Qing M,et al.Identification of five interfer-on-induced cellular proteins that inhibit west nile virus and denguevirus infections[J].J Virol,2010,84(16):8332-8341.
  • 4Huang I C,Bailey C C,Weyer J L,et al.Distinct patterns of IF-ITM mediated restriction of filoviruses,SARS coronavirus,and in-fluenza A virus[J].PLos Pathog.2011,7(1):e1001258.
  • 5Hisamatsu T,Watanabe M,Ogata H,et al.Interferon-induciblegene family 1-8U expression in colitis-associated colon cancer andseverely inflamed mucosa in ulcerative colitis[J].Cancer Res,1999,59:5927-5931.
  • 6Andreu P,Colnot S,Godard C,et al.Identification of the IFITMfamily as a new molecular marker in human colorectal tumors[J].Cancer Res,2006,66:1949-1955.
  • 7Fan J,Peng Z,Zhou C,et al.Gene-expression profiling in Chinesepatients with colon cancer by coupling experimental and bioinformat-ic genomewide gene-expression analyses:identification and valida-tion of IFITM3 as a biomarker of early colon carcinogenesis[J].Cancer,2008,113(2):266-275.
  • 8Yang Y,Lee J H,Kim K Y,et al.The interferon-inducible 9–27 gene modulates the susceptibility to natural killer cells and theinvasiveness of gastric cancer cells[J].Cancer Lett,2005,221:191-200.
  • 9Seyfried N T,Huysentruyt L C,Atwood J A,et al.Up-regulation ofNG2 proteoglycan and interferon-induced transmembrane proteins 1and 3 in mouse astrocytoma:a membrane proteomics approach[J].Cancer Lett,2008,263:243-252.
  • 10Seo G S,Lee J K,Yu J I,et al.Identification of the polymor-phisms in IFITM3 gene and their association in a Korean populationwith ulcerative colitis[J].Exp Mol Med,2010,42(2):99-104.

同被引文献15

  • 1Jemal A, Bray F, Center M M, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
  • 2Kudo M. Adjuvant therapy after curative treatment for hepatocellular carcinoma[J]. Oncology, 2011, 81(Suppl 1):50-55.
  • 3Hickford D, Frankenberg S, Shaw G, et al. Evolution of vertebrate interferon inducible transmembrane proteins[J]. BMC Genomics, 2012, 13:155. doi: 10.1186/1471-2164-13-155.
  • 4Reid LE, Brasnett AH, Gilbert CS, et al. A single DNA response element can confer inducibility by both alpha- and gamma-interferons[J]. Proc Natl Acad Sci U S A, 1989, 86(3):840-844.
  • 5Bailey CC, Kondur HR, Huang IC, et al. Interferon-induced transmembrane protein 3 is a type II transmembrane protein[J]. J Biol Chem, 2013, 288(45):32184-32193.
  • 6Lu J, Pan Q, Rong L, et al. The IFITM proteins inhibit HIV-1 infection[J]. J Virol, 2011, 85(5):2126-2137.
  • 7Andreu P, Colnot S, Godard C, et al. Identification of the IFITM family as a new molecular marker in human colorectal tumors[J]. Cancer Res, 2006, 66(4):1949-1955.
  • 8Brem R, Oraszlan-Szovik K, Foser S, et al. Inhibition of proliferation by 1-8U in interferon-alpha-responsive and non-responsive cell lines[J]. Cell Mol Life Sci, 2003, 60(6):1235-1248.
  • 9Li D, Peng Z, Tang H, et al. KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis[J]. Clin Cancer Res, 2011, 17(11):3558-3568.
  • 10Yori JL, Johnson E, Zhou G, et al. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression[J]. J Biol Chem, 2010, 285(22):16854-16863.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部